TAM
EPZM

Tocqueville Asset Management’s Epizyme, Inc EPZM Stock Holding History

Tocqueville Asset Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-25,000
Closed -$256K – 858
2016
Q2 		$256K Hold
25,000
– – ﹤0.01% 750
2016
Q1 		$303K Buy
25,000
+4,500
+22% +$45.5K ﹤0.01% 729
2015
Q4 		$328K Hold
20,500
– – ﹤0.01% 752
2015
Q3 		$264K Buy
+20,500
New +$414K ﹤0.01% 836

Other funds holding EPZM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Tocqueville Asset Management's EPZM Position: Q3 2016 in Review

Tocqueville Asset Management sold out of Epizyme, Inc (EPZM) in Q3 2016, closing a stake of 25,000 shares — an estimated $256K sold.

Tocqueville Asset Management first reported a position in EPZM in Q3 2015 and held it in 4 quarters. The position peaked at $328K in Q4 2015. 97 funds tracked by Wall St. Rank hold EPZM as of Q3 2016.

  • Tocqueville Asset Management reported no remaining Epizyme, Inc position as of Q3 2016 after selling out during the quarter.
  • Tocqueville Asset Management sold 25,000 Epizyme, Inc shares in Q3 2016, an estimated $256K.
  • Tocqueville Asset Management first reported a position in Epizyme, Inc in Q3 2015 and held it in 4 quarters.
  • Tocqueville Asset Management's Epizyme, Inc position peaked at $328K in Q4 2015.
  • 97 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2016.

Based on Tocqueville Asset Management's 13F filing for Q3 2016, filed 31 Oct 2016.